Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22143103 | 0.76 | — | — | |
| SCHEMBL16223205 | 0.74 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL14999389 | 0.69 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL7860374 | 0.67 | — | — | |
| SCHEMBL27687843 | 0.67 | — | — | |
| SCHEMBL29556546 | 0.67 | — | — | |
| SCHEMBL31182127 | 0.67 | — | — | |
| SCHEMBL6057228 | 0.67 | CHRM2 (0.38) | ALDH1A1 | |
| SCHEMBL11102471 | 0.65 | ALDH1A1 (0.32) | ALDH1A1 | |
| Phosphine SCHEMBL28910692 | 0.63 | ALDH1A1 (0.31) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767376-B2 | Catalyst mixture | ARLANXEO NETHERLANDS B.V. (NL) | 2023-09-26 | — | — | US | disclosed |
| US-11578148-B2 | Metal complex comprising amidine and thiophene fused cyclopentadienyl ligands | ARLANXEO NETHERLANDS B.V. | 2023-02-14 | — | — | US | disclosed |
| US-11560394-B2 | Metal complex comprising amidine and indole fused cyclopentadienyl ligands | ARLANXEO NETHERLANDS B.V. | 2023-01-24 | — | — | US | disclosed |
| US-20220056162-A1 | CATALYST MIXTURE | ARLANXEO NETHERLANDS B.V. (NL) | 2022-02-24 | — | — | US | disclosed |
| EP-3732183-B1 | METAL COMPLEX COMPRISING AMIDINE AND THIOPHENE FUSED CYCLOPENTADIENYL LIGANDS | Arlanxeo Netherlands Bv (NL) | 2021-10-20 | — | — | EP | disclosed |
| EP-3853265-A1 | CATALYST MIXTURE | Arlanxeo Netherlands B.V. (NL) | 2021-07-28 | — | — | EP | disclosed |
| US-20210087305-A1 | METAL COMPLEX COMPRISING AMIDINE AND THIOPHENE FUSED CYCLOPENTADIENYL LIGANDS | ARLANXEO NETHERLANDS B.V. (NL) | 2021-03-25 | — | — | US | disclosed |
| EP-3781582-A1 | METAL COMPLEX COMPRISING AMIDINE AND INDOLE FUSED CYCLOPENTADIENYL LIGANDS | Arlanxeo Netherlands B.V. (NL) | 2021-02-24 | — | — | EP | disclosed |
| EP-3732183-A1 | METAL COMPLEX COMPRISING AMIDINE AND THIOPHENE FUSED CYCLOPENTADIENYL LIGANDS | Arlanxeo Netherlands B.V. (NL) | 2020-11-04 | — | — | EP | disclosed |
| EP-3334768-B1 | CATALYST SYSTEM | Arlanxeo Netherlands Bv (NL) | 2020-05-27 | — | — | EP | disclosed |
| US-10316113-B2 | Catalyst system | ARLANXEO NETHERLANDS B.V. (NL) | 2019-06-11 | — | — | US | disclosed |
| US-20180237553-A1 | CATALYST SYSTEM | ARLANXEO NETHERLANDS B.V. (NL) | 2018-08-23 | — | — | US | disclosed |
| EP-3334768-A1 | CATALYST SYSTEM | Arlanxeo Netherlands B.V. (NL) | 2018-06-20 | — | — | EP | disclosed |
| EP-3272761-A1 | METALL COMPLEX COMPRISING AMIDINE AND SUBSTITUTED CYCLOPENTADIENYL LIGANDS | Arlanxeo Netherlands B.V. (NL) | 2018-01-24 | — | — | EP | disclosed |
| US-20170240663-A1 | METAL COMPLEX COMPRISING AMIDINE AND SUBSTITUTED CYCLOPENTADIENYL LIGANDS | ARLANXEO NETHERLANDS B.V. (NL) | 2017-08-24 | — | — | US | disclosed |
| EP-3194412-A1 | METAL COMPLEX COMPRISING AMIDINE AND SUBSTITUTED CYCLOPENTADIENYL LIGANDS | Arlanxeo Netherlands B.V. (NL) | 2017-07-26 | — | — | EP | disclosed |
| WO-2017029141-A1 | CATALYST SYSTEM | ARLANXEO NETHERLANDS B.V. (NL) | 2017-02-23 | — | — | WO | disclosed |
| EP-2801579-B1 | Metal complex with a Lewis base ligand | Arlanxeo Netherlands Bv (NL) | 2016-10-19 | — | — | EP | disclosed |
| WO-2016041818-A1 | METAL COMPLEX COMPRISING AMIDINE AND SUBSTITUTED CYCLOPENTADIENYL LIGANDS | LANXESS ELASTOMERS B.V. (NL) | 2016-03-24 | — | — | WO | disclosed |
| EP-2801579-A1 | Metal complex with a Lewis base ligand | Lanxess Elastomers B.V. (NL) | 2014-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210087305-A1 | METAL COMPLEX COMPRISING AMIDINE AND THIOPHENE FUSED CYCLOPENTADIENYL LIGANDS | AP3M1, AP2M1, AP1M1 | ALDH1A1 4736/4885 |
| US-11560394-B2 | Metal complex comprising amidine and indole fused cyclopentadienyl ligands | C5, C1S, CLIC4 | ALDH1A1 4269/4885 |
| US-20170240663-A1 | METAL COMPLEX COMPRISING AMIDINE AND SUBSTITUTED CYCLOPENTADIENYL LIGANDS | AP2M1, AP1M1, STAMBP | ALDH1A1 4400/4885 |
| US-11578148-B2 | Metal complex comprising amidine and thiophene fused cyclopentadienyl ligands | AP3M1, AP2M1, AP1M1 | ALDH1A1 4736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.